Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor B of the alternative complement pathway on human lymphocytes

L Halbwachs, P J Lachmann

    Scandinavian Journal of Immunology
    |January 1, 1976
    PubMed
    Summary

    Human lymphocytes possess factor B, crucial for the alternative complement pathway. This factor can be secreted by lymphocytes, playing a role in immune responses and C3 convertase formation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency<sup>1</sup>.

    Clinical and experimental immunology·2020
    Same author

    Further studies of the down-regulation by Factor I of the C3b feedback cycle using endotoxin as a soluble activator and red cells as a source of CR1 on sera of different complotype.

    Clinical and experimental immunology·2015
    Same author

    Studies with monoclonal antibodies to complement components.

    Immunology today·2014
    Same author

    Complotype affects the extent of down-regulation by Factor I of the C3b feedback cycle in vitro.

    Clinical and experimental immunology·2014
    Same author

    Tissue-and metal-specific effects of thiolacrylic acids in rats.

    Biological trace element research·2013
    Same author

    The penumbra of thalidomide, the litigation culture and the licensing of pharmaceuticals.

    QJM : monthly journal of the Association of Physicians·2012

    Area of Science:

    • Immunology
    • Complement System Biology

    Background:

    • The alternative pathway of the complement system is vital for innate immunity.
    • Factor B is a key component in the fluid phase formation of C3 convertase.

    Purpose of the Study:

    • To identify the source and nature of a factor on human lymphocytes involved in complement activation.
    • To investigate the role of lymphocytes in the alternative complement pathway.

    Main Methods:

    • Utilized Burkitt lymphoma cell lines cultured without a factor B source.
    • Employed cobra venom factor (CVF) to induce C3 convertase formation.
    • Tested inhibition with anti-human factor B antibodies.
    • Assessed C3-converting activity in cell supernatants.
    • Investigated the effect of sodium azide and cytochalasin B.

    Main Results:

    • Human lymphocytes were identified to possess factor B of the alternative pathway.
    • Lymphocytes could substitute for fluid-phase factor B in C3 convertase formation with CVF.
    • This lymphocyte activity was inhibited by anti-human factor B antibodies.
    • C3-converting activity was found in the cell supernatant after CVF reaction.
    • Factor B was not detected antigenically on the lymphocyte membrane and may be secreted.

    Conclusions:

    • Lymphocytes contain and can secrete factor B, a critical component of the alternative complement pathway.
    • This finding elucidates a novel mechanism for complement activation involving lymphocytes.
    • The study differentiates lymphocyte-associated factor B from the C3b receptor.

    Related Experiment Videos